跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Biosaph-Plus - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Biosaph-Plus
Approved
STANDARD
Biosaph-Plus
Sapphire Lifesciences Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
76553d198a89e91f
Company
Sapphire Lifesciences Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
76553d198a89e91f
Drug Approval Philippines Name
Biosaph-Plus
Product Name
Biosaph-Plus
Registration Number
DRP-14691
Brand Name
Biosaph-Plus
Generic Name
Paracetamol + Phenylephrine Hydrochloride + Chlorphenamine Maleate
Dosage Form
Capsule
Dosage Strength
500 mg/10 mg/2 mg
Manufacturer
Sapphire Lifesciences Pvt. Ltd.
Importer
Nelpa Lifesciences, Inc.
Distributor
Nelpa Lifesciences, Inc.
Issuance Date
28 November 2023
Expiry Date
28 November 2028
Classification
ver-the-Counter (OTC) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
76553d198a89e91f
Type
Standard
Back to Philippines FDA Approvals